Evidence map›Paper›PMID 39253972›Full record

ArticleJCI insight2024

Inhibiting endothelial cell Mst1 attenuates acute lung injury in mice.

Zhi-Fu Guo, Nopprarat Tongmuang, Chao Li, Chen Zhang, Louis Hu, Daniel Capreri, Mei-Xing Zuo, Ross Summer, Jianxin Sun

Abstract read
In one paragraph

Article in JCI insight, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Zhi-Fu GuoCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Nopprarat TongmuangCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Chao LiCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Chen ZhangCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Louis HuCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Daniel CapreriCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Mei-Xing ZuoCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Ross SummerCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Jianxin SunCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Funding

Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung InjuryR01HL152703 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI SUMMER, ROSS S, SUN, JIANXIN · 2021 to 2024
$2.8M
Prevention of anthracycline-induced cardiotoxicity by Nur77 activationR01HL159168 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI SUN, JIANXIN · 2021 to 2024
$2.1M
NHLBI NIH HHS R01 HL152703NHLBI NIH HHS R01 HL159168
6 · The paper itself

Abstract

Lung endothelium plays a pivotal role in the orchestration of inflammatory responses to acute pulmonary insults. Mammalian sterile 20-like kinase 1 (Mst1) is a serine/threonine kinase that has been shown to play an important role in the regulation of apoptosis, stress responses, and organ growth. This study investigated the role of Mst1 in lung endothelial activation and acute lung injury (ALI). We found that Mst1 was significantly activated in inflamed lung endothelial cells (ECs) and mouse lung tissues. Overexpression of Mst1 promoted nuclear factor κ-B (NF-κB) activation through promoting JNK and p38 activation in lung ECs. Inhibition of Mst1 by either its dominant negative form (DN-Mst1) or its pharmacological inhibitor markedly attenuated cytokine-induced expression of cytokines, chemokines, and adhesion molecules in lung ECs. Importantly, in a mouse model of lipopolysaccharide-induced (LPS-induced) ALI, both deletion of Mst1 in lung endothelium and treatment of WT mice with a pharmacological Mst1 inhibitor significantly protected mice from LPS-induced ALI. Together, our findings identified Mst1 kinase as a key regulator in controlling lung EC activation and suggest that therapeutic strategies aimed at inhibiting Mst1 activation might be effective in the prevention and treatment of inflammatory lung diseases.

Indexed as

Acute Lung InjuryEndothelial CellsLipopolysaccharidesLungProtein Serine-Threonine KinasesAnimalsCytokinesDisease Models, AnimalHepatocyte Growth FactorHippo KinasesHumansMaleMiceMice, Inbred C57BLMice, KnockoutNF-kappa BCytokinesHepatocyte Growth FactorHippo KinasesLipopolysaccharidesmacrophage stimulating proteinNF-kappa BProtein Serine-Threonine KinasesProto-Oncogene ProteinsStk4 protein, mouseCytokinesEndothelial cellsInflammationNF-kappaBVascular biology

Identifiers

PMID39253972
PMCPMC11385092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.